Zoetis Inc. Cost of Revenue
Zoetis Inc. (ZTS) reported Cost of Revenue of $673.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-06
- Zoetis Inc. cost of goods and services sold for the quarter ending 2026-06-30 was $673.00M, a 1.36% increase year-over-year.
- Zoetis Inc. cost of goods and services sold for the quarter ending 2026-03-31 was $641.00M, a 3.72% increase year-over-year.
- Zoetis Inc. cost of goods and services sold for the quarter ending 2025-12-31 was $712.00M, a 0.71% increase year-over-year.
- Zoetis Inc. cost of goods and services sold for the quarter ending 2025-09-30 was $683.00M, a 2.57% decline year-over-year.
- Zoetis Inc. cost of goods and services sold for fiscal 2025 was $2.67B, a 1.95% decline from fiscal 2024.
- Zoetis Inc. cost of goods and services sold for fiscal 2024 was $2.72B, a 6.17% increase from fiscal 2023.
- Zoetis Inc. cost of goods and services sold for fiscal 2023 was $2.56B, a 4.36% increase from fiscal 2022.
- Zoetis Inc. cost of goods and services sold for fiscal 2022 was $2.45B, a 6.56% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $673.00M 10-Q · filed 2026-08-06 | $1.31B 10-Q · filed 2026-08-06 | $2.03B derived: sum of 3 quarters · filed 2026-08-06 | $2.71B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $641.00M 10-Q · filed 2026-05-07 | $1.35B derived: sum of 2 quarters · filed 2026-05-07 | $2.04B derived: sum of 3 quarters · filed 2026-05-07 | $2.70B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $712.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.40B derived: sum of 2 quarters · filed 2026-02-12 | $2.06B derived: sum of 3 quarters · filed 2026-08-06 | $2.67B 10-K · filed 2026-02-12 | ||
| 2025-09-30 | $683.00M 10-Q · filed 2025-11-04 | $1.35B derived: sum of 2 quarters · filed 2026-08-06 | $1.95B 10-Q · filed 2025-11-04 | $2.67B derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | $664.00M 10-Q · filed 2026-08-06 | $649.00M 10-Q · filed 2025-08-05 | $1.28B 10-Q · filed 2026-08-06 | $1.27B 10-Q · filed 2025-08-05 | $1.99B derived: sum of 3 quarters · filed 2026-08-06 | $2.69B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $618.00M 10-Q · filed 2026-05-07 | $622.00M 10-Q · filed 2025-05-06 | $1.32B derived: sum of 2 quarters · filed 2026-05-07 | $2.03B derived: sum of 3 quarters · filed 2026-05-07 | $2.69B derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $707.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.41B derived: sum of 2 quarters · filed 2026-02-12 | $2.08B derived: sum of 3 quarters · filed 2026-02-12 | $2.72B 10-K · filed 2026-02-12 | ||
| 2024-09-30 | $701.00M 10-Q · filed 2025-11-04 | $1.37B derived: sum of 2 quarters · filed 2025-11-04 | $2.01B 10-Q · filed 2025-11-04 | $2.74B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-06-30 | $668.00M 10-Q · filed 2025-08-05 | $1.31B 10-Q · filed 2025-08-05 | $2.04B derived: sum of 3 quarters · filed 2026-02-12 | $2.68B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2024-03-31 | $643.00M 10-Q · filed 2025-05-06 | $1.37B derived: sum of 2 quarters · filed 2026-02-12 | $2.01B derived: sum of 3 quarters · filed 2026-02-12 | $2.62B derived: sum of 4 quarters · filed 2026-02-12 | ||
| 2023-12-31 | $728.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $1.37B derived: sum of 2 quarters · filed 2026-02-12 | $1.97B derived: sum of 3 quarters · filed 2026-02-12 | $2.56B 10-K · filed 2026-02-12 | ||
| 2023-09-30 | $638.00M 10-Q · filed 2024-11-04 | $1.25B derived: sum of 2 quarters · filed 2024-11-04 | $1.83B 10-Q · filed 2024-11-04 | $2.49B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-06-30 | $607.00M 10-Q · filed 2024-08-06 | $1.20B 10-Q · filed 2024-08-06 | $1.85B derived: sum of 3 quarters · filed 2025-02-13 | $2.46B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-03-31 | $588.00M 10-Q · filed 2024-05-02 | $1.24B derived: sum of 2 quarters · filed 2025-02-13 | $1.85B derived: sum of 3 quarters · filed 2025-02-13 | $2.47B derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2022-12-31 | $653.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $1.26B derived: sum of 2 quarters · filed 2025-02-13 | $1.89B derived: sum of 3 quarters · filed 2025-02-13 | $2.45B 10-K · filed 2025-02-13 | ||
| 2022-09-30 | $607.00M 10-Q · filed 2023-11-02 | $1.23B derived: sum of 2 quarters · filed 2023-11-02 | $1.80B 10-Q · filed 2023-11-02 | $2.40B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-06-30 | $625.00M 10-Q · filed 2023-08-08 | $1.19B 10-Q · filed 2023-08-08 | $1.79B derived: sum of 3 quarters · filed 2024-02-13 | $2.38B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2022-03-31 | $569.00M 10-Q · filed 2023-05-04 | $1.17B derived: sum of 2 quarters · filed 2024-02-13 | $1.75B derived: sum of 3 quarters · filed 2024-02-13 | $2.32B derived: sum of 4 quarters · filed 2024-02-13 | ||
| 2021-12-31 | $600.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $1.19B derived: sum of 2 quarters · filed 2024-02-13 | $1.75B derived: sum of 3 quarters · filed 2024-02-13 | $2.30B 10-K · filed 2024-02-13 | ||
| 2021-09-30 | $586.00M 10-Q · filed 2022-11-03 | $1.15B derived: sum of 2 quarters · filed 2022-11-03 | $1.70B 10-Q · filed 2022-11-03 | $2.30B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-06-30 | $568.00M 10-Q · filed 2022-08-04 | $1.12B 10-Q · filed 2022-08-04 | $1.72B derived: sum of 3 quarters · filed 2023-02-14 | $2.26B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-03-31 | $549.00M 10-Q · filed 2022-05-05 | $1.15B derived: sum of 2 quarters · filed 2023-02-14 | $1.70B derived: sum of 3 quarters · filed 2023-02-14 | $2.15B derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2020-12-31 | $601.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $1.15B derived: sum of 2 quarters · filed 2023-02-14 | $1.60B derived: sum of 3 quarters · filed 2023-02-14 | $2.06B 10-K · filed 2023-02-14 | ||
| 2020-09-30 | $546.00M 10-Q · filed 2021-11-04 | $997.00M derived: sum of 2 quarters · filed 2021-11-04 | $1.46B 10-Q · filed 2021-11-04 | $1.99B derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2020-06-30 | $451.00M 10-Q · filed 2021-08-05 | $910.00M 10-Q · filed 2021-08-05 | $1.44B derived: sum of 3 quarters · filed 2022-02-15 | $1.92B derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2020-03-31 | $459.00M 10-Q · filed 2021-05-06 | $989.00M derived: sum of 2 quarters · filed 2022-02-15 | $1.47B derived: sum of 3 quarters · filed 2022-02-15 | $1.93B derived: sum of 4 quarters · filed 2022-02-15 | ||
| 2019-12-31 | $530.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $1.01B derived: sum of 2 quarters · filed 2022-02-15 | $1.47B derived: sum of 3 quarters · filed 2022-02-15 | $1.99B 10-K · filed 2022-02-15 | ||
| 2019-09-30 | $479.00M 10-Q · filed 2020-11-05 | $944.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.46B 10-Q · filed 2020-11-05 | $2.01B derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-06-30 | $465.00M 10-Q · filed 2020-08-06 | $983.00M 10-Q · filed 2020-08-06 | $1.53B derived: sum of 3 quarters · filed 2021-02-16 | $2.00B derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2019-03-31 | $518.00M 10-Q · filed 2020-05-06 | $1.06B derived: sum of 2 quarters · filed 2021-02-16 | $1.53B derived: sum of 3 quarters · filed 2021-02-16 | $1.98B derived: sum of 4 quarters · filed 2021-02-16 | ||
| 2018-12-31 | $544.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | $1.02B derived: sum of 2 quarters · filed 2021-02-16 | $1.46B derived: sum of 3 quarters · filed 2021-02-16 | $1.91B 10-K · filed 2021-02-16 | ||
| 2018-09-30 | $473.00M 10-Q · filed 2019-11-07 | $920.00M derived: sum of 2 quarters · filed 2019-11-07 | $1.37B 10-Q · filed 2019-11-07 | $1.82B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-06-30 | $447.00M 10-Q · filed 2019-08-06 | $894.00M 10-Q · filed 2019-08-06 | $1.35B derived: sum of 3 quarters · filed 2020-02-13 | $1.79B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-03-31 | $447.00M 10-Q · filed 2019-05-02 | $904.00M derived: sum of 2 quarters · filed 2020-02-13 | $1.34B derived: sum of 3 quarters · filed 2020-02-13 | $1.78B derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2017-12-31 | $457.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $892.00M derived: sum of 2 quarters · filed 2020-02-13 | $1.33B derived: sum of 3 quarters · filed 2020-02-13 | $1.77B 10-K · filed 2020-02-13 | ||
| 2017-10-01 | $435.00M 10-Q · filed 2018-11-01 | $875.00M derived: sum of 2 quarters · filed 2018-11-01 | $1.32B 10-Q · filed 2018-11-01 | $1.79B derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-07-02 | $440.00M 10-Q · filed 2018-08-02 | $883.00M 10-Q · filed 2018-08-02 | $1.35B derived: sum of 3 quarters · filed 2019-02-14 | $1.76B derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2017-04-02 | $443.00M 10-Q · filed 2018-05-02 | $911.00M derived: sum of 2 quarters · filed 2019-02-14 | $1.32B derived: sum of 3 quarters · filed 2019-02-14 | $1.72B derived: sum of 4 quarters · filed 2019-02-14 | ||
| 2016-12-31 | $468.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $878.00M derived: sum of 2 quarters · filed 2019-02-14 | $1.28B derived: sum of 3 quarters · filed 2019-02-14 | $1.67B 10-K · filed 2019-02-14 | ||
| 2016-10-02 | $410.00M 10-Q · filed 2017-11-02 | $809.00M derived: sum of 2 quarters · filed 2017-11-02 | $1.20B 10-Q · filed 2017-11-02 | $1.69B derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-07-03 | $399.00M 10-Q · filed 2017-08-08 | $788.00M 10-Q · filed 2017-08-08 | $1.28B derived: sum of 3 quarters · filed 2018-02-15 | $1.71B derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2016-04-03 | $389.00M 10-Q · filed 2017-05-04 | $885.00M derived: sum of 2 quarters · filed 2018-02-15 | $1.31B derived: sum of 3 quarters · filed 2018-02-15 | $1.73B derived: sum of 4 quarters · filed 2018-02-15 | ||
| 2015-12-31 | $496.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $917.00M derived: sum of 2 quarters · filed 2018-02-15 | $1.34B derived: sum of 3 quarters · filed 2018-02-15 | $1.74B 10-K · filed 2018-02-15 | ||
| 2015-09-27 | $421.00M 10-Q · filed 2016-11-03 | $848.00M derived: sum of 2 quarters · filed 2016-11-03 | $1.24B 10-Q · filed 2016-11-03 | $1.73B derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-06-28 | $427.00M 10-Q · filed 2016-08-05 | $821.00M 10-Q · filed 2016-08-05 | $1.31B derived: sum of 3 quarters · filed 2017-02-16 | $1.75B derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2015-03-29 | $394.00M 10-Q · filed 2016-05-06 | $885.00M derived: sum of 2 quarters · filed 2017-02-16 | $1.32B derived: sum of 3 quarters · filed 2017-02-16 | $1.73B derived: sum of 4 quarters · filed 2017-02-16 | ||
| 2014-12-31 | $491.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16 | $925.00M derived: sum of 2 quarters · filed 2017-02-16 | $1.34B derived: sum of 3 quarters · filed 2017-02-16 | $1.72B 10-K · filed 2017-02-16 | ||
| 2014-09-28 | $434.00M 10-Q · filed 2015-11-05 | $847.00M derived: sum of 2 quarters · filed 2015-11-05 | $1.23B 10-Q · filed 2015-11-05 | $1.69B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-29 | $413.00M 10-Q · filed 2015-08-06 | $792.00M 10-Q · filed 2015-08-06 | $1.26B derived: sum of 3 quarters · filed 2016-02-24 | $1.64B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-30 | $379.00M 10-Q · filed 2015-05-07 | $845.00M derived: sum of 2 quarters · filed 2016-02-24 | $1.23B derived: sum of 3 quarters · filed 2016-02-24 | $1.65B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2013-12-31 | $466.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $851.00M derived: sum of 2 quarters · filed 2016-02-24 | $1.27B derived: sum of 3 quarters · filed 2016-02-24 | $1.67B 10-K · filed 2016-02-24 | ||
| 2013-09-29 | $385.00M 10-Q · filed 2014-11-10 | $801.00M derived: sum of 2 quarters · filed 2014-11-10 | $1.20B 10-Q · filed 2014-11-10 | $1.64B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-06-30 | $416.00M 10-Q · filed 2014-08-12 | $818.00M 10-Q · filed 2014-08-12 | $1.25B derived: sum of 3 quarters · filed 2015-02-27 | $1.61B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2013-03-31 | $402.00M 10-Q · filed 2014-05-13 | $835.00M derived: sum of 2 quarters · filed 2015-02-27 | $1.19B derived: sum of 3 quarters · filed 2015-02-27 | $1.57B derived: sum of 4 quarters · filed 2015-02-27 | ||
| 2012-12-31 | $433.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $792.00M derived: sum of 2 quarters · filed 2015-02-27 | $1.17B derived: sum of 3 quarters · filed 2015-02-27 | $1.56B 10-K · filed 2015-02-27 | ||
| 2012-09-30 | $359.00M 10-Q · filed 2013-11-13 | $737.00M derived: sum of 2 quarters · filed 2013-11-13 | $1.13B 10-Q · filed 2013-11-13 | |||
| 2012-07-01 | $378.00M 10-Q · filed 2013-08-14 | $771.00M 10-Q · filed 2013-08-14 | ||||
| 2012-04-01 | $393.00M 10-Q · filed 2013-05-15 | |||||
| 2011-12-31 | $1.65B 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |